Product Reports Resources Pricing Login Book a demo
COMPANY PROFILE

Cellular Origins

Request full access

Enabling patient access to cell therapies for today and tomorrow

Royston, United KingdomFounded 2022Biotech & Life Sciences

At a glance

Status
Operational
Employees
105
Open positions
4
Dealroom signal
56.2/100
Industry
Health
Sub-industry
Pharmaceutical, BioTechnology
Sector
Biotechnology, Biotech and Pharma, Cell Therapy, Techbio, Lab Automation, DT and LS, science-based
Technology
Hardware, Deep Tech
Business model
Manufacturing
Client focus
B2B

Funding history

1 recorded event

Company financing events and reported valuations.

Deal typeDateAmountValuationInvestorsSource
SERIES A✓Equity / VC Dec 2025 $40M $160M Business Growth Fund · NYBC Ventures · Highland Europe · TTP Group ↗
Showing the latest 1 of 1 recorded eventsBook a demo for the full funding history →

Growth signals

Cellular Origins website traffic

Latest recorded traffic for Cellular Origins is 2.4K monthly website visits, down 66.2% over the last three months. Cellular Origins's team grew 32.9% over the past year.

Latest monthly visits2.4K 3-month web change-66.2% 1-year team growth+32.9%
Summary metrics are public; monthly history is available with a demoCompare with peers →

Similar companies

Closest operating peers by Dealroom taxonomy

Company identity and context are open; selected comparison metrics preview what is available on the platform.

Showing 8 of the closest matchesCompare every metric →

Investments and acquisitions

Capital deployed

Recent portfolio relationships for companies that also act as investors or acquirers.

Cellular Origins in the Royston ecosystem

Live from Dealroom

The Cellular Origins office with the hot startups, most funded companies and investors around it. Hover or tap a pin.

Loading the map…

Dealroom maps whole ecosystems like this one for cities, regions and governments. See the ecosystem platform →

Investors

5 investors on the cap table

From Dealroom's funding and investor records, grouped by the round each investor first entered.

Series A5 investors entered at this stage

  • Johnson & Johnson
  • Business Growth Fund
  • NYBC Ventures
  • Highland Europe
  • TTP Group
Team profiled 4 named & role-tagged
Founders Hidden — book a demo/100 quality score
Key operators Hidden — book a demo quality score
Potential founders Hidden — book a demo likely future founders
Startup mafia Hidden — book a demo alumni-founded startups
Talent movements Hidden — book a demo in · Hidden — book a demo out past 12 months

Source: Dealroom Talent Intelligence.

See Cellular Origins’s full profile on Dealroom

Request a free trial to see the complete deal history, financials, people graph and growth signals.

Takes under a minute. Already use Dealroom? Log in.